Core LaboratoriesCLB
CLB
About: Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Employees: 3,500
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
118% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 17
53% more call options, than puts
Call options by funds: $279K | Put options by funds: $182K
9% more funds holding
Funds holding: 190 [Q3] → 207 (+17) [Q4]
0.27% less ownership
Funds ownership: 108.54% [Q3] → 108.27% (-0.27%) [Q4]
7% less capital invested
Capital invested by funds: $943M [Q3] → $880M (-$63.6M) [Q4]
19% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 72
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$16
7%
upside
Avg. target
$16
7%
upside
High target
$16
7%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Citigroup Scott Gruber 47% 1-year accuracy 34 / 72 met price target | 7%upside $16 | Neutral Upgraded | 12 Mar 2025 |
Financial journalist opinion
Neutral
PRNewsWire
1 week ago
CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025.
Positive
Zacks Investment Research
4 weeks ago
Is Core Stock Worth Buying After a 27% Surge in 6 Months?
CLB stock is supported by international expansion, proprietary tech and solid cash flow amid competitive pricing, volatile oil prices and geopolitical tensions.
Negative
Zacks Investment Research
1 month ago
Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Positive
Zacks Investment Research
1 month ago
CLB's Q4 Earnings Beat Estimates, Sales Lag, Expenses Increase
Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025.
Neutral
Seeking Alpha
1 month ago
Core Laboratories Inc. (CLB) Q4 2024 Earnings Conference Call Transcript
Core Laboratories Inc. (NYSE:CLB ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Josh Jayne - Daniel Energy Partners David Smith - Pickering Energy Partners Operator Good day, and welcome to the Core Laboratories' Fourth Quarter 2024 Earnings Call. All participants will be in listen-only mode.
Negative
Zacks Investment Research
2 months ago
Core Laboratories (CLB) Misses Q4 Earnings and Revenue Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.19 per share a year ago.
Neutral
PRNewsWire
2 months ago
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEAR FOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND FULL YEAR REVENUE OF $523.8 MILLION, UP 3% FULL YEAR OPERATING INCOME OF $58.6 MILLION; EX-ITEMS, $65.3 MILLION, UP 7% FULL YEAR GAAP EPS OF $0.66; EX-ITEMS, EPS OF $0.87, UP 9% FULL YEAR FREE CASH FLOW OF $43.4 MILLION, UP OVER 200% COMPARED TO 2023 HOUSTON , Jan. 29, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2024 revenue of $129,200,000. Core's operating income was $14,200,000, with diluted earnings per share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP").
Positive
Zacks Investment Research
2 months ago
Core Laboratories to Post Q4 Earnings: Here's What to Expect
CLB is expected to report higher revenues from the year-ago period's level. However, despite this revenue growth, the company is expected to face increased operating expenses.
Positive
Zacks Investment Research
2 months ago
Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
Zacks Investment Research
2 months ago
Here's Why Hold Strategy is Apt for Core Laboratories Stock Now
CLB benefits from strong international growth, high-margin projects and an efficient business model. However, stock underperformance, competition and U.S. market challenges pose risks.
Charts implemented using Lightweight Charts™